Prostate cancer usually develops slowly, so there may be no signs of the health condition for many years, but once the tumour grows large enough, there will be signs.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Bladder cancer is one of the most common type of cancer in the UK, with over 10,000 people diagnosed every year. And it is the eighth most common cancer in men. The University of Sheffield and ...

Bladder cancer has a cure rate of over 90% when detected early, but it has a high recurrence rate of 70%, necessitating ...

but yet the level of awareness about bladder cancer in the UK remains low.' The trial was funded by AstraZeneca, with the results published in the New England Journal of Medicine. At the moment ...

but yet the level of awareness about bladder cancer in the UK remains low.” At the moment, around half of patients with muscle-invasive bladder cancer experience recurrence within three years.

Bladder cancer is the ninth most common cancer in the UK, with 17,000 diagnoses and 5,000 deaths in England each year, according to the university. It has the highest lifetime treatment costs per ...

Armando, a 71-year-old with an active lifestyle, was midway through a round of golf when a strange sensation crept into his ...

Revolutionary research shows statins combined with new PIN1 inhibitors could transform bladder cancer treatment, offering hope to thousands of patients.

Innovative fluorescence-based diagnostic system identifies early-stage bladder cancer with 90% accuracy, utilizing untreated ...

and Merck says it anticipates a target action date by the regulator in January 2020. Keytruda has already been approved for other forms of bladder cancer, as have five of the six other approved ...